Identifying possible asthma-COPD overlap syndrome in patients with a new diagnosis of COPD in primary care

被引:13
作者
Baarnes, Camilla Boslev [1 ]
Kjeldgaard, Peter [1 ]
Nielsen, Mia [1 ]
Miravitlles, Marc [2 ]
Ulrik, Charlotte Suppli [1 ,3 ]
机构
[1] Hvidovre Univ Hosp, Dept Pulm Med, Hvidovre, Denmark
[2] Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain
[3] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
关键词
OBSTRUCTIVE PULMONARY-DISEASE; HIGH-RISK POPULATION; FLUTICASONE PROPIONATE; GUIDELINES; PHENOTYPE; FEATURES;
D O I
10.1038/npjpcrm.2016.84
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
The asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) remains poorly characterised. Our aim was to describe an algorithm for identifying possible ACOS in adults with newly diagnosed COPD in primary care. General practitioners (n = 241) consecutively recruited subjects >= 35 years, with tobacco exposure, at least one respiratory symptom and no previous diagnosis of obstructive lung disease. Possible ACOS was defined as chronic airflow obstruction, i.e., post-bronchodilator (BD) forced expiratory volume 1/forced vital capacity (FEV1/FVC) ratio < 0.70, combined with wheeze (ACOS wheeze) and/or significant BD reversibility (ACOS BD reversibility). Of 3,875 (50% females, mean age 57 years) subjects screened, 700 (18.1%) were diagnosed with COPD, i.e., symptom(s), tobacco exposure and chronic airflow obstruction. Indications for ACOS were found in 264 (38%) of the COPD patients. The prevalence of ACOS wheeze and ACOS BD reversibility was 27% (n = 190) and 16% (n = 113), respectively (P<0.001), and only 6% (n = 39) of the COPD patients fulfilled both criteria for ACOS. Patients with any ACOS were younger (P = 0.04), had more dyspnoea (P<0.001), lower FEV1% pred (67% vs. 74%; P<0.001) and lower FEV1/FVC ratio (P = 0.001) compared with COPD-only patients. Comparing subjects fulfilling both criteria for ACOS with those fulfilling criteria for ACOS wheeze only (n = 151) and those fulfilling criteria for ACOS BD reversibility only (n = 74) revealed no significant differences. Irrespective of the applied ACOS definition, no significant difference in life-time tobacco exposure was found between ACOS- and COPD-only patients. In subjects with a new diagnosis of COPD, the prevalence of ACOS is high. When screening for COPD in general practice among patients with no previous diagnosis of obstructive lung disease, patients with possible ACOS may be identified by self-reported wheeze and/or BD reversibility.
引用
收藏
页数:6
相关论文
共 44 条
[1]
Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD? [J].
Barrecheguren, Miriam ;
Roman-Rodriguez, Miguel ;
Miravitlles, Marc .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :1745-1752
[2]
The asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges [J].
Barrecheguren, Miriam ;
Esquinas, Cristina ;
Miravitlles, Marc .
CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (01) :74-79
[3]
The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? [J].
Bateman, Eric D. ;
Reddel, Helen K. ;
van Zyl-Smit, Richard N. ;
Agusti, Alvar .
LANCET RESPIRATORY MEDICINE, 2015, 3 (09) :719-728
[4]
Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study [J].
Bateman, Eric D. ;
Ferguson, Gary T. ;
Barnes, Neil ;
Gallagher, Nicola ;
Green, Yulia ;
Henley, Michelle ;
Banerji, Donald .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) :1484-1494
[5]
Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study [J].
Beeh, Kai-Michael ;
Korn, Stephanie ;
Beier, Jutta ;
Jadayel, Dalal ;
Henley, Michelle ;
D'Andrea, Peter ;
Banerji, Donald .
RESPIRATORY MEDICINE, 2014, 108 (04) :584-592
[6]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[7]
Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study [J].
Brzostek, Dorota ;
Kokot, Marek .
POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (06) :372-379
[8]
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[9]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[10]
Characteristics and self-rated health of overlap syndrome [J].
Chung, Jung Wha ;
Kong, Kyoung Ae ;
Lee, Jin Hwa ;
Lee, Seok Jeong ;
Ryu, Yon Ju ;
Chang, Jung Hyun .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 :795-804